[KLexpat]

>The AJM hasn't recommended anything. AJM has published a paper titled "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection". >It hasn't published it "now". It has published it back in August of 2020.

"The American Journal of Medicine, Vol 134, No 1, January 2021", Page 18, shows a treatment algorithm for Covid-19-like and confirmed Covid-19 illness, specifying 200mg of Hydroxochloroquine for patients over the age of 50 or with a single comorbidity.

I'm not talking about the primary study on HCQ, but the treatment algorithm is recent.